Congratulations! BiOptic has won the 28th Taiwan Small and Medium Enterprises Innovation Award!
2021-11-22
BiOptic has won the 28th Taiwan Small and Medium Enterprises Innovation Award for its "Qsep1-Lite Bio-Fragment Analyzer" from the Ministry of Economic Affairs, R.O.C.
BiOptic has certificated by UL in conformance with FDA 21 CFR Part 11
2021-02-19
The software system of Qsep series bio-fragment analyzer, Q-Analyzer, which is developed by BiOptic, has certificated by UL in conformance with FDA 21 CFR Part 11 in Jan 2021. The FDA guidelines for Data Integrity include the requirement for compliance for the storage of electronic records. Nearly all the medical-related industries follow this standard, which gains on the safety of information security and data management of the product. The data retained in this standard can be used as an effective source for future tracking.
As the weather turned cooler in parts of the northern hemisphere, the COVID-19 pandemic is getting serious again in lots of countries. From the beginning of this pandemic, every health organization around the world has put a lot of efforts on finding the right strategy to stop it. Somehow, it seems that there is no effective way.
Rapid, Automated and High-Resolution Nucleic Acid Quality Control Solutions for NGS using CE
2021-01-14
Nucleic acid Quality Control (QC) is an essential component of next-generation sequencing (NGS) workflow. Verifying nucleic acid quality and concentration at checkpoints – from genomic DNA (gDNA) integrity check to final library fragment distribution check – helps to ensure successful sequencing outcomes.
Thanks for the efforts of our distributors all over the world. Although COVID-19 crushes the world economy, BiOptic is still growing while facing this pandemic. Due to the increasing number of orders, our production efficiency almost reaches its limit, so we decided to enlarge the space of our production line to fulfill the market demand. The headquarter of BiOptic Inc. will be relocated to the next building beside our existing ones from 12/19 to 12/20.
BiOptic Inc. won A+ Industrial Innovation R&D Program
2020-11-13
The winner of A+ Industrial Innovation R&D Program has been announced a few days ago. Based on our breakthrough technology and R&D Vision and Directions, BiOptic Inc. was finally selected by the committee and received the subsidies after several rounds of competition between many outstanding manufacturers throughout the world. Perhaps, the growing market share of BiOptic's products in over 50 countries might also be part of the winning factors.
